STAT

STAT+: Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx

Amgen will acquire ChemoCentryx for $4 billion to obtain a newly approved medicine that treats patients with a serious autoimmune condition.
Source: Alex Hogan/STAT

Top of the morning to you. Another steamy day is unfolding here at the Pharmalot campus, where the short person will soon leave

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Pfizer Drug For Duchenne, Bird Flu Vaccines For Cows, And More
Pfizer reported that its gene therapy for Duchenne muscular dystrophy failed to slow disease progression in a Phase 3 trial.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders Dogging Novo Nordisk, Teva Patents, And More
U.S. Senate health committee chair Bernie Sanders called a vote to subpoena the chief of Novo Nordisk’s U.S. division over pricing of Ozempic and Wegovy.
STAT1 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Alzheimer’s Drug, The GSK-Elsie Deal, And More
In today's Pharmalittle roundup, we're reading about Eli Lilly's Alzheimer's drug, the GSK-Elsie deal, and more.

Related Books & Audiobooks